Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 113 entries
Sorted by: Best Match Show Resources per page
Measurement of the quality of life in congestive heart failure--influence of drug therapy.

Cardiovascular drugs and therapy

Bulpitt CJ, Fletcher AE.
PMID: 3154651
Cardiovasc Drugs Ther. 1988 Nov;2:419-24.

In cardiovascular diseases such as hypertension, drug therapy may improve survival and the drug of choice is the one that interferes least with health-related well-being, otherwise known as the quality of life. However, in angina, and possibly congestive heart...

Cite
Bulpitt CJ, Fletcher AE. Measurement of the quality of life in congestive heart failure--influence of drug therapy. Cardiovasc Drugs Ther. 1988;2:419-24
Bulpitt, C. J., & Fletcher, A. E. (1988). Measurement of the quality of life in congestive heart failure--influence of drug therapy. Cardiovascular drugs and therapy, 2419-24.
Bulpitt, C J, and Fletcher, A E. "Measurement of the quality of life in congestive heart failure--influence of drug therapy." Cardiovascular drugs and therapy vol. 2 (1988): 419-24.
Bulpitt CJ, Fletcher AE. Measurement of the quality of life in congestive heart failure--influence of drug therapy. Cardiovasc Drugs Ther. 1988 Nov;2:419-24. PMID: 3154651.
Copy Download .nbib Format: NLM
[Congestive heart failure: some mechanisms and therapeutic implications].

Harefuah

Hertzianu H, Pines A.
PMID: 1879774
Harefuah. 1991 Mar 15;120(6):347-50.

No abstract available.

Cite
Hertzianu H, Pines A. [Congestive heart failure: some mechanisms and therapeutic implications]. Harefuah. 1991;120(6):347-50
Hertzianu, H., & Pines, A. (1991). [Congestive heart failure: some mechanisms and therapeutic implications]. Harefuah, 120(6), 347-50.
Hertzianu, H, and Pines, A. "[Congestive heart failure: some mechanisms and therapeutic implications]." Harefuah vol. 120,6 (1991): 347-50.
Hertzianu H, Pines A. [Congestive heart failure: some mechanisms and therapeutic implications]. Harefuah. 1991 Mar 15;120(6):347-50. Hebrew. PMID: 1879774.
Copy Download .nbib Format: NLM
Measurement of quality of life in clinical trials of therapy.

Cardiology

Fletcher AE, Bulpitt CJ.
PMID: 3069215
Cardiology. 1988;75:41-52. doi: 10.1159/000174444.

This article discusses some of the issues involved in the use of quality of life methods to evaluate treatment, primarily in trials of cardiovascular disease. The choice of aspects to measure is influenced by the severity and nature of...

Cite
Fletcher AE, Bulpitt CJ. Measurement of quality of life in clinical trials of therapy. Cardiology. 1988;75:41-52doi: 10.1159/000174444.
Fletcher, A. E., & Bulpitt, C. J. (1988). Measurement of quality of life in clinical trials of therapy. Cardiology, 7541-52. https://doi.org/10.1159/000174444
Fletcher, A E, and Bulpitt, C J. "Measurement of quality of life in clinical trials of therapy." Cardiology vol. 75 (1988): 41-52. doi: https://doi.org/10.1159/000174444
Fletcher AE, Bulpitt CJ. Measurement of quality of life in clinical trials of therapy. Cardiology. 1988;75:41-52. doi: 10.1159/000174444. PMID: 3069215.
Copy Download .nbib Format: NLM
The medical treatment of congestive heart failure.

Boletin de la Asociacion Medica de Puerto Rico

Hernández López E.
PMID: 2486900
Bol Asoc Med P R. 1989 Jan;81(1):2-14.

The data herein presented provides persuasive evidence that in addition to diuretics, and probably digitalis (since all studies have included subjects taking this drug) patients with congestive heart failure should also be placed on a vasodilator regimen to slow...

Cite
Hernández López E. The medical treatment of congestive heart failure. Bol Asoc Med P R. 1989;81(1):2-14
Hernández López, E. (1989). The medical treatment of congestive heart failure. Boletin de la Asociacion Medica de Puerto Rico, 81(1), 2-14.
Hernández López, E. "The medical treatment of congestive heart failure." Boletin de la Asociacion Medica de Puerto Rico vol. 81,1 (1989): 2-14.
Hernández López E. The medical treatment of congestive heart failure. Bol Asoc Med P R. 1989 Jan;81(1):2-14. PMID: 2486900.
Copy Download .nbib Format: NLM
Recent advances in the control of heart failure. Nice, France, June 20, 1990.

American heart journal

[No authors listed]
PMID: 1672052
Am Heart J. 1991 Mar;121(3):949-88.

No abstract available.

Cite
Recent advances in the control of heart failure. Nice, France, June 20, 1990. Am Heart J. 1991;121(3):949-88
(1991). Recent advances in the control of heart failure. Nice, France, June 20, 1990. American heart journal, 121(3), 949-88.
"Recent advances in the control of heart failure. Nice, France, June 20, 1990." American heart journal vol. 121,3 (1991): 949-88.
Recent advances in the control of heart failure. Nice, France, June 20, 1990. Am Heart J. 1991 Mar;121(3):949-88. PMID: 1672052.
Copy Download .nbib Format: NLM
Treatment of mild congestive heart failure. The potential for new drugs to reduce the risks.

Drug safety

Ravens U, Wehr M.
PMID: 1793520
Drug Saf. 1991 Nov-Dec;6(6):393-401. doi: 10.2165/00002018-199106060-00001.

No abstract available.

Cite
Ravens U, Wehr M. Treatment of mild congestive heart failure. The potential for new drugs to reduce the risks. Drug Saf. 1991;6(6):393-401doi: 10.2165/00002018-199106060-00001.
Ravens, U., & Wehr, M. (1991). Treatment of mild congestive heart failure. The potential for new drugs to reduce the risks. Drug safety, 6(6), 393-401. https://doi.org/10.2165/00002018-199106060-00001
Ravens, U, and Wehr, M. "Treatment of mild congestive heart failure. The potential for new drugs to reduce the risks." Drug safety vol. 6,6 (1991): 393-401. doi: https://doi.org/10.2165/00002018-199106060-00001
Ravens U, Wehr M. Treatment of mild congestive heart failure. The potential for new drugs to reduce the risks. Drug Saf. 1991 Nov-Dec;6(6):393-401. doi: 10.2165/00002018-199106060-00001. PMID: 1793520.
Copy Download .nbib Format: NLM
[Views on the treatment of congestive heart failure].

Kardiologia polska

Halawa B.
PMID: 1942757
Kardiol Pol. 1991;35(8):125-31.

No abstract available.

Cite
Halawa B. Poglady na leczenie zastoinowej niewydolności krazenia. [Views on the treatment of congestive heart failure]. Kardiol Pol. 1991;35(8):125-31
Halawa, B. (1991). Poglady na leczenie zastoinowej niewydolności krazenia. [Views on the treatment of congestive heart failure]. Kardiologia polska, 35(8), 125-31.
Halawa, B. "Poglady na leczenie zastoinowej niewydolności krazenia." [Views on the treatment of congestive heart failure]. Kardiologia polska vol. 35,8 (1991): 125-31.
Halawa B. Poglady na leczenie zastoinowej niewydolności krazenia. [Views on the treatment of congestive heart failure]. Kardiol Pol. 1991;35(8):125-31. Polish. PMID: 1942757.
Copy Download .nbib Format: NLM
[How to read the basal ECG in the patient with heart failure?].

Giornale italiano di cardiologia

[No authors listed]
PMID: 8076739
G Ital Cardiol. 1994 May;24(5):609-11.

No abstract available.

Cite
Come leggere l'ECG basale nel paziente con scompenso cardiaco? [How to read the basal ECG in the patient with heart failure?]. G Ital Cardiol. 1994;24(5):609-11
(1994). Come leggere l'ECG basale nel paziente con scompenso cardiaco? [How to read the basal ECG in the patient with heart failure?]. Giornale italiano di cardiologia, 24(5), 609-11.
"Come leggere l'ECG basale nel paziente con scompenso cardiaco?" [How to read the basal ECG in the patient with heart failure?]. Giornale italiano di cardiologia vol. 24,5 (1994): 609-11.
Come leggere l'ECG basale nel paziente con scompenso cardiaco? [How to read the basal ECG in the patient with heart failure?]. G Ital Cardiol. 1994 May;24(5):609-11. Italian. PMID: 8076739.
Copy Download .nbib Format: NLM
Considering dose in pharmacological therapies for heart failure - Authors' reply.

Lancet (London, England)

Vaduganathan M, Fonarow GC, McMurray JJV, Solomon SD.
PMID: 33485443
Lancet. 2021 Jan 23;397(10271):275. doi: 10.1016/S0140-6736(21)00090-8.

No abstract available.

Cite
Vaduganathan M, Fonarow GC, McMurray JJV, et al. Considering dose in pharmacological therapies for heart failure - Authors' reply. Lancet. 2021;397(10271):275doi: 10.1016/S0140-6736(21)00090-8.
Vaduganathan, M., Fonarow, G. C., McMurray, J. J. V., & Solomon, S. D. (2021). Considering dose in pharmacological therapies for heart failure - Authors' reply. Lancet (London, England), 397(10271), 275. https://doi.org/10.1016/S0140-6736(21)00090-8
Vaduganathan, Muthiah, et al. "Considering dose in pharmacological therapies for heart failure - Authors' reply." Lancet (London, England) vol. 397,10271 (2021): 275. doi: https://doi.org/10.1016/S0140-6736(21)00090-8
Vaduganathan M, Fonarow GC, McMurray JJV, Solomon SD. Considering dose in pharmacological therapies for heart failure - Authors' reply. Lancet. 2021 Jan 23;397(10271):275. doi: 10.1016/S0140-6736(21)00090-8. PMID: 33485443.
Copy Download .nbib Format: NLM
Clinical Effects of Early and Short-Term Tolvaptan Administration in Patients Hospitalized for Acute Decompensated Heart Failure.

Cardiology

Tanaka N, Dan K, Maeda T, Ishihara H, Teramura M, Ichihashi K, Takahashi Y, Tsuzura D, Shinoda A, Fujii M, Okada H, Teramoto T.
PMID: 34348260
Cardiology. 2021;146(6):739-747. doi: 10.1159/000518732. Epub 2021 Aug 03.

INTRODUCTION: Previous trials showed that tolvaptan improves acute heart failure (HF). However, the optimal timing for administering tolvaptan to achieve the best outcome remains unclear. Therefore, the current study investigated the relationship between the timing of tolvaptan treatment initiation...

Cite
Tanaka N, Dan K, Maeda T, et al. Clinical Effects of Early and Short-Term Tolvaptan Administration in Patients Hospitalized for Acute Decompensated Heart Failure. Cardiology. 2021;146(6):739-747doi: 10.1159/000518732.
Tanaka, N., Dan, K., Maeda, T., Ishihara, H., Teramura, M., Ichihashi, K., Takahashi, Y., Tsuzura, D., Shinoda, A., Fujii, M., Okada, H., & Teramoto, T. (2021). Clinical Effects of Early and Short-Term Tolvaptan Administration in Patients Hospitalized for Acute Decompensated Heart Failure. Cardiology, 146(6), 739-747. https://doi.org/10.1159/000518732
Tanaka, Nobukiyo, et al. "Clinical Effects of Early and Short-Term Tolvaptan Administration in Patients Hospitalized for Acute Decompensated Heart Failure." Cardiology vol. 146,6 (2021): 739-747. doi: https://doi.org/10.1159/000518732
Tanaka N, Dan K, Maeda T, Ishihara H, Teramura M, Ichihashi K, Takahashi Y, Tsuzura D, Shinoda A, Fujii M, Okada H, Teramoto T. Clinical Effects of Early and Short-Term Tolvaptan Administration in Patients Hospitalized for Acute Decompensated Heart Failure. Cardiology. 2021;146(6):739-747. doi: 10.1159/000518732. Epub 2021 Aug 03. PMID: 34348260.
Copy Download .nbib Format: NLM
[Changes in medical treatment of heart failure in the light of large clinical trials].

Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology

Sinagra G, Sabbadini G, Di Lenarda A, Gortan R, Massa L, Carniel E, Driussi M.
PMID: 11255893
Ital Heart J Suppl. 2001 Feb;2(2):97-115.

In the last years, the treatment of heart failure has radically changed, as has knowledge of this complex and heterogeneous clinical syndrome. This is largely due to the results of several multicenter clinical trials, which have been undertaken since...

Cite
Sinagra G, Sabbadini G, Di Lenarda A, et al. Come è cambiata la terapia medica dello scompenso cardiaco alla luce dei grandi trial clinici. [Changes in medical treatment of heart failure in the light of large clinical trials]. Ital Heart J Suppl. 2001;2(2):97-115
Sinagra, G., Sabbadini, G., Di Lenarda, A., Gortan, R., Massa, L., Carniel, E., & Driussi, M. (2001). Come è cambiata la terapia medica dello scompenso cardiaco alla luce dei grandi trial clinici. [Changes in medical treatment of heart failure in the light of large clinical trials]. Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2(2), 97-115.
Sinagra, G, et al. "Come è cambiata la terapia medica dello scompenso cardiaco alla luce dei grandi trial clinici." [Changes in medical treatment of heart failure in the light of large clinical trials]. Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology vol. 2,2 (2001): 97-115.
Sinagra G, Sabbadini G, Di Lenarda A, Gortan R, Massa L, Carniel E, Driussi M. Come è cambiata la terapia medica dello scompenso cardiaco alla luce dei grandi trial clinici. [Changes in medical treatment of heart failure in the light of large clinical trials]. Ital Heart J Suppl. 2001 Feb;2(2):97-115. Italian. PMID: 11255893.
Copy Download .nbib Format: NLM
Pharmacotherapy of congestive heart failure. Currently used and experimental drugs.

Pharmacy world & science : PWS

van Zwieten PA.
PMID: 7889021
Pharm World Sci. 1994 Dec 02;16(6):234-42. doi: 10.1007/BF02178563.

A survey is given of the currently used therapeutics in the treatment of chronic congestive heart failure. Symptomatic treatment is usually performed along the following lines: rest, sodium and fluid restriction to unload the decompensating heart, loop diuretics, angiotensin-converting...

Cite
van Zwieten PA. Pharmacotherapy of congestive heart failure. Currently used and experimental drugs. Pharm World Sci. 1994;16(6):234-42doi: 10.1007/BF02178563.
van Zwieten, P. A. (1994). Pharmacotherapy of congestive heart failure. Currently used and experimental drugs. Pharmacy world & science : PWS, 16(6), 234-42. https://doi.org/10.1007/BF02178563
van Zwieten, P A. "Pharmacotherapy of congestive heart failure. Currently used and experimental drugs." Pharmacy world & science : PWS vol. 16,6 (1994): 234-42. doi: https://doi.org/10.1007/BF02178563
van Zwieten PA. Pharmacotherapy of congestive heart failure. Currently used and experimental drugs. Pharm World Sci. 1994 Dec 02;16(6):234-42. doi: 10.1007/BF02178563. PMID: 7889021.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 113 entries